These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32182358)

  • 1. SuperCYPsPred-a web server for the prediction of cytochrome activity.
    Banerjee P; Dunkel M; Kemmler E; Preissner R
    Nucleic Acids Res; 2020 Jul; 48(W1):W580-W585. PubMed ID: 32182358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CypRules: a rule-based P450 inhibition prediction server.
    Shao CY; Su BH; Tu YS; Lin C; Lin OA; Tseng YJ
    Bioinformatics; 2015 Jun; 31(11):1869-71. PubMed ID: 25617412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rule-Based Prediction Models of Cytochrome P450 Inhibition.
    Su BH; Tu YS; Lin C; Shao CY; Lin OA; Tseng YJ
    J Chem Inf Model; 2015 Jul; 55(7):1426-34. PubMed ID: 26108525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes.
    Plonka W; Stork C; Šícho M; Kirchmair J
    Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
    Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
    J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Cytochrome P450 Inhibition Using a Deep Learning Approach and Substructure Pattern Recognition.
    Chen Z; Zhang L; Zhang P; Guo H; Zhang R; Li L; Li X
    J Chem Inf Model; 2024 Apr; 64(7):2528-2538. PubMed ID: 37864562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization.
    Doohan PT; Oldfield LD; Arnold JC; Anderson LL
    AAPS J; 2021 Jun; 23(4):91. PubMed ID: 34181150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
    Qiu JX; Zhou ZW; He ZX; Zhang X; Zhou SF; Zhu S
    Drug Des Devel Ther; 2015; 9():841-66. PubMed ID: 25733806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study.
    Basińska-Ziobroń A; Daniel WA; Wójcikowski J
    Pharmacol Rep; 2015 Dec; 67(6):1178-82. PubMed ID: 26481538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
    Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
    J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational prediction of cytochrome P450 inhibition and induction.
    Kato H
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):30-44. PubMed ID: 31902468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
    Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
    Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.
    Maréchal JD; Kemp CA; Roberts GC; Paine MJ; Wolf CR; Sutcliffe MJ
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S82-9. PubMed ID: 18026129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.
    Brown HS; Galetin A; Hallifax D; Houston JB
    Clin Pharmacokinet; 2006; 45(10):1035-50. PubMed ID: 16984215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into drug metabolism from modelling studies of cytochrome P450-drug interactions.
    Maréchal JD; Sutcliffe MJ
    Curr Top Med Chem; 2006; 6(15):1619-26. PubMed ID: 16918473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Hwang-Ryun-Hae-Dok-Tang on cytochrome P450 in human liver microsomes.
    Lee SY; Jang H; Lee JY; Ma JY; Oh SJ; Kim SK
    Xenobiotica; 2015 Feb; 45(2):131-8. PubMed ID: 25145883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms.
    Dmitriev AV; Rudik AV; Karasev DA; Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
    Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
    Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.